Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M20,520Revenue $M751Net Margin (%)-17.8Z-Score13.1
Enterprise Value $M20,231EPS $-0.9Operating Margin %-12.4F-Score4
P/E(ttm))0Cash Flow Per Share $-0.1Pre-tax Margin (%)-16.6Higher ROA y-yY
Price/Book12.410-y EBITDA Growth Rate %0Quick Ratio5.2Cash flow > EarningsY
Price/Sales25.25-y EBITDA Growth Rate %0Current Ratio6.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-5.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-9.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M147ROI % (ttm)-9.2Gross Margin Increase y-yY

Gurus Latest Trades with BMRN

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BMRNJohn Griffin 2014-09-30 Add0.11%$55.78 - $73
($65.82)
$ 129.1449%Add 6.19%2,230,000
BMRNFrank Sands 2014-06-30 Add0.35%$56.15 - $68.61
($60.38)
$ 129.1453%Add 22.47%11,925,248
BMRNRay Dalio 2014-06-30 Sold Out -0.03%$56.15 - $68.61
($60.38)
$ 129.1453%Sold Out0
BMRNJohn Burbank 2014-06-30 Sold Out -0.01%$56.15 - $68.61
($60.38)
$ 129.1453%Sold Out0
BMRNRay Dalio 2014-03-31 Buy 0.03%$64.99 - $83.28
($73.66)
$ 129.1443%New holding48,400
BMRNJohn Burbank 2014-03-31 Buy 0.01%$64.99 - $83.28
($73.66)
$ 129.1443%New holding5,173
BMRNJohn Griffin 2013-12-31 Add0.23%$59.3 - $75.09
($67.74)
$ 129.1448%Add 17.71%2,060,000
BMRNFrank Sands 2013-09-30 Reduce-0.2%$58.64 - $78.388
($66.48)
$ 129.1449%Reduce -9.49%10,268,812
BMRNMeridian Funds 2013-06-30 Sold Out -0.09%$54.72 - $70.3
($62.32)
$ 129.1452%Sold Out0
BMRNFrank Sands 2013-03-31 Add0.24%$49.2 - $62.39
($56.51)
$ 129.1456%Add 10.90%10,951,298
BMRNMeridian Funds 2013-03-31 Reduce-0.17%$49.2 - $62.39
($56.51)
$ 129.1456%Reduce -69.03%40,700
BMRNFrank Sands 2012-12-31 Add1.56%$36.78 - $50.17
($45.59)
$ 129.1465%Add 450.74%9,874,728
BMRNDaniel Loeb 2012-12-31 Sold Out -0.79%$36.78 - $50.17
($45.59)
$ 129.1465%Sold Out0
BMRNMeridian Funds 2012-12-31 Reduce-0.3%$36.78 - $50.17
($45.59)
$ 129.1465%Reduce -60.99%131,400
BMRNJohn Griffin 2012-12-31 Reduce-0.28%$36.78 - $50.17
($45.59)
$ 129.1465%Reduce -20.09%1,750,000
BMRNJohn Griffin 2012-09-30 Buy 1.4%$37.23 - $43.29
($39.41)
$ 129.1469%New holding2,190,000
BMRNDaniel Loeb 2012-09-30 Buy 0.79%$37.23 - $43.29
($39.41)
$ 129.1469%New holding1,000,000
BMRNGeorge Soros 2012-06-30 Sold Out -0.15%$32.53 - $38.87
($36.01)
$ 129.1472%Sold Out0
BMRNAndreas Halvorsen 2012-06-30 Sold Out -0.12%$32.53 - $38.87
($36.01)
$ 129.1472%Sold Out0
BMRNRichard Perry 2012-06-30 Sold Out -0.04%$32.53 - $38.87
($36.01)
$ 129.1472%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BMRN is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


BMRN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BIENAIME JEAN JACQUESCEO 2015-03-20Sell1,000$126.4-8.58view
BIENAIME JEAN JACQUESCEO 2015-03-17Sell2,000$124.17-6.94view
FUCHS HENRY JEVP, Chief Medical Officer 2015-03-16Sell41,315$123.57-6.49view
Davis George EricSVP, General Counsel 2015-03-13Sell15,000$120.87-4.4view
BIENAIME JEAN JACQUESCEO 2015-03-10Sell21,021$112.392.81view
BIENAIME JEAN JACQUESCEO 2015-03-05Sell10,000$113.71.63view
BAFFI ROBERTEVP, Technical Operations 2015-03-05Sell14,051$116.37-0.7view
BIENAIME JEAN JACQUESCEO 2015-03-04Sell13,916$107.927.07view
LAPALME PIERREDirector 2015-03-03Sell20,000$106.578.43view
Mueller BrianVP, Corporate Controller 2015-03-03Sell7,000$109.465.56view

Press Releases about BMRN :

    Quarterly/Annual Reports about BMRN:

    News about BMRN:

    Articles On GuruFocus.com
    You Can No Longer Ignore Biotech Feb 07 2014 
    Weekly Top Insider Sells: AAPL, GILD, BMRN, and PCLN Nov 19 2012 
    WEEKLY CFO SELLS HIGHLIGHT: VVUS, DIS, SNPS, TXRH, BMRN Mar 05 2012 
    5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
    Weekly CFO Sells Highlight: MSCC, BMRN, VAL, CUTR, REX, CIEN Oct 02 2011 
    BioMarin Pharmaceutical Inc. Reports Operating Results (10-K) Feb 24 2011 
    BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques Bienaime sells 1,000 Shares Dec 13 2010 
    BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques Bienaime sells 2,000 Shares Dec 13 2010 
    BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques Bienaime sells 1,000 Shares Dec 07 2010 
    BioMarin Pharmaceutical Inc. (BMRN) SVP, CFO Jeffrey H Cooper sells 11,250 Shares Nov 24 2010 

    More From Other Websites
    BioMarin jumps after analyst suggests merger may be in its future Mar 27 2015
    RBC Has 4 Biotech Stocks to Buy After Massive Pullback Mar 27 2015
    BUZZ-Shire: Gattex, Natpara & Vyvanse possible blockbusters-UBS Mar 27 2015
    Biotech Stock Selloff: Is It Justified? Mar 26 2015
    The Biotech Selloff: It's Déjà Vu All Over Again Mar 26 2015
    Palo Alto Rejoicing at ABIOMED, Inc. (ABMD)’s 18% Spike Mar 25 2015
    Profit takers active as biotech stalls Mar 24 2015
    Cramer's stocks to watch: Amazing biotech Mar 23 2015
    Biotech's path to discovery: BioMarin CEO Mar 23 2015
    Biotech Bull Market: The Two Best Ways to Play It Mar 18 2015
    How the Weaker Euro Is Impacting Biotech Earnings Mar 18 2015
    BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Mar 18 2015
    Cramer: This sector has tons of hidden opportunity Mar 16 2015
    BioMarin Pharmaceutical (BMRN) Jumps: Stock Moves Up 6.9% - Tale of the Tape Mar 16 2015
    Short Sellers Still Attracted To Biotech Stocks Mar 13 2015
    Lightning Round: Good chance this is downgraded Mar 12 2015
    18 Biotech Stocks These Wall Street Analysts Are Tracking Mar 11 2015
    United Therapeutics Wins FDA Nod, Priority Voucher Mar 10 2015
    BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Change in Directors or Principal Officers Mar 06 2015
    The Next 3 Likely Biotech Buyout Candidates Mar 06 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK